Search results
A Tampa cancer research firm just raised $22.6M. What comes next?
Tampa Bay Times, St. Petersburg, Fla. via Yahoo News· 2 years agoWhen the founders of Tampa cancer research company Morphogenesis asked Jim Bianco about coming in as CEO in early 2021, they told him they were working on a cancer vaccine. His response? “Ah ...
Can Pfizer Stock Double Your Money in 3 Years?
Motley Fool· 12 months agoPfizer (NYSE: PFE) has been a losing play for investors over the past 12 months. To wit: The drugmaker's stock has fallen by a whopping 28.8% over this...
Sanofi (SNY) Q3 2022 Earnings Call Transcript
Motley Fool· 2 years agoImage source: The Motley Fool. Sanofi (NASDAQ: SNY)Q3 2022 Earnings CallOct 28, 2022, 8:30 a.m. ETContents: Prepared Remarks Questions and Answers Call...
1 Green Flag and 1 Red Flag for Provention Bio
Motley Fool· 2 years agoJust ask Provention Bio (NASDAQ: PRVB). The headwinds related to teplizumab have played a critical role in Provention Bio's poor performance over the...
7 Stocks to Sell Now
InvestorPlace via Yahoo Finance· 2 years agoIn 2022, the stock market has faced a plethora of negative factors, from the Russian invasion of Ukraine and the soaring energy prices that followed to...
5 of the Safest High-Yield Dividend Stocks to Buy for 2024
Motley Fool via Yahoo Finance· 5 months agoThese supercharged dividend stocks, with yields ranging from 5.4% to 10.5%, offer highly favorable...
Ready for a Rebound: 7 Blue-Chips Set to Regain Their Market Mojo
InvestorPlace via Yahoo Finance· 11 months agoWhile the smaller-capitalization trades tend to attract the most speculative attention, for reliable...
FTSE 100 Live: London blue-chips climb, AstraZeneca results, Flutter and S4 Capital shares tumble
Evening Standard via Yahoo Finance UK· 6 months agoA packed session of blue-chip updates has led to some big share price moves, with Flutter...